The results of this randomised, double-blind, double-dummy, placebo-controlled, parallel-group study demonstrate the efficacy of loratadine and fexofenadine in relieving the common symptoms of SAR, ...
Two hundred and ninety-nine patients were enrolled according to the protocol, and of these, 11 were excluded for per-protocol analysis. The excluded patients did not reach the required severity rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results